MedPath

Effect of folic acid and vitamin B6; Prevention of postpartum depressio

Phase 1
Conditions
Postpartum Depression.
Puerperal psychosis
Registration Number
IRCT20090801002266N19
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
105
Inclusion Criteria

Pregnant women 18 to 45 years old
Women should be in the third trimester of pregnancy.
People have a previous history of depression or anxiety based on history.
People have a positive family history of depression.
7 to 15 anxiety or depression score based on HADS screening questionnaire
People have a low or very low social support score in the NSSQ social support questionnaire.

Exclusion Criteria

Women who give birth under 37 weeks.
Women who have a score below 7 and a score above 15 of anxiety or depression based on the HADS screening questionnaire.
Lack of consent to participate in the study
Women with treatment for depression or any type of psychiatric disorder
Women under medical treatment due to high-risk pregnancy
Women with limited mobility due to high-risk pregnancy
Women with a history of receiving folic acid at a dose greater than 1 mg per day or a history of receiving B6 daily

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postpartum depression score based on the Edinburgh Postpartum Depression Scale. Timepoint: before the intervention and one and a half months after delivery. Method of measurement: In this research, it is measured by questionnaire and interview method. These questionnaires include 1- Demographic Characteristics Questionnaire 2- HADS 2 Questionnaire 3- Edinburgh Depression Questionnaire 4- Social Support Questionnaire (NSSQ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath